StockData
Caris Life Sciences, Inc. logo

Caris Life Sciences, Inc. (CAI) stock

CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3084% above fair value
$18.54−0.96 (-4.92%)

Close on Nov 19, 2026Market cap $5.24BP/E –Yield –

Caris Life Sciences shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Caris Life Sciences's shares outstanding was 295M at Sep 30, 2026. For fiscal 2025 it was 167M, up 371.0% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025167M+371.0%
FY2024Dec 31, 202435M+1.6%
FY2023Dec 31, 202335M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026295M-0.7%
Q2 FY2026Jun 30, 2026283M+335.8%
Q1 FY2026Mar 31, 2026283M+693.2%
Q4 FY2025Dec 31, 2025283M+695.0%
Q3 FY2025Sep 30, 2025297M+733.8%
Q2 FY2025Jun 30, 202565M+83.5%
Q1 FY2025Mar 31, 202536M–
Q4 FY2024Dec 31, 202436M–
Q3 FY2024Sep 30, 202436M–
Q2 FY2024Jun 30, 202435M–

More Caris Life Sciences figures

See a number that looks wrong?